chitosan has been researched along with tamoxifen in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 16 (69.57) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Dhiman, HK; Panda, AK; Ray, AR | 1 |
| Auger, FA; Berthod, F; Germain, L; Tremblay, PL | 1 |
| Dharmala, K; Lee, CH; Yoo, JW | 1 |
| Coppi, G; Iannuccelli, V | 1 |
| Baggio, G; Bruni, E; Coppi, G; Iannuccelli, V; Rossi, T | 1 |
| Bilensoy, E; Calis, S; Capan, Y; Cirpanli, Y; Erdogar, N; Gegu, C; Launay, M; Leturgez, T; Ozturk, K; Yerlikaya, F | 1 |
| Barbieri, S; Bettini, R; Buttini, F; Colombo, G; Colombo, P; Como, C; Rossi, A; Sonvico, F; Zani, F | 1 |
| Arana, P; Blanco, MD; Fernández, A; Martínez, A; Olmo, R; Teijón, C | 1 |
| Agudelo, D; Nafisi, S; Sanyakamdhorn, S; Tajmir-Riahi, HA | 1 |
| Kannan, S; Nipun Babu, V; Subramanian, KS; Thangam, R; Vivek, R | 1 |
| Agudelo, D; Chanphai, P; Nafisi, Sh; Sanyakamdhorn, S; Tajmir-Riahi, HA | 1 |
| Barbieri, S; Bettini, R; Buttini, F; Colombo, G; Colombo, P; Ponchel, G; Rossi, A; Sonvico, F | 1 |
| Bhushan, S; Dadarwal, M; Guru, SK; Katare, OP; Kumar, P; Raza, K; Sharma, G; Thotakura, N | 1 |
| Jena, SK; Sangamwar, AT | 1 |
| Chitkara, D; Kumar, P; Kumar, R; Raza, K; Singh, B; Thakur, CK; Thotakura, N | 1 |
| Chand, M; Jena, SK; Kaur, S; Samal, SK; Sangamwar, AT | 1 |
| Dadarwal, M; Katare, OP; Kumar, P; Kumar, R; Raza, K; Sharma, G; Singh, B; Thotakura, N | 1 |
| Chanphai, P; Tajmir-Riahi, HA; Thomas, TJ | 1 |
| Abdellatif, KRA; Abo El-Ela, FI; F, AG; Kharshoum, RM; Salem, HF | 1 |
| Gautam, N; Kathle, PK; Kesavan, K | 1 |
| Criado-Gonzalez, M; Fernandez-Gutierrez, M; Hernández, R; Mijangos, C; San Roman, J | 1 |
| Goodarzi, MT; Nekoei, M; Nokhodi, F | 1 |
| Abd-Allah, FI; Abu Elyazid, SK; El-Sawy, HS; El-Say, KM; Ismael, HR; Lila, AE; Megahed, MA; Reda, AM | 1 |
23 other study(ies) available for chitosan and tamoxifen
| Article | Year |
|---|---|
Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen.
Topics: Antineoplastic Agents; Apoptosis; Biocompatible Materials; Breast Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Materials Testing; Membranes, Artificial; Tamoxifen; Tissue Engineering | 2005 |
In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue.
Topics: Angiogenesis Inhibitors; Capillaries; Chitosan; Collagen; Connective Tissue; Dermis; Drug Evaluation, Preclinical; Endothelial Cells; Endothelium, Vascular; Glycosaminoglycans; Humans; Hydroxamic Acids; Hypoxia; Immunohistochemistry; Indoles; Infant, Newborn; Intercellular Signaling Peptides and Proteins; Peptides; Tamoxifen; Tissue Engineering; Umbilical Veins; Vascular Endothelial Growth Factor A | 2005 |
Development of chitosan-SLN microparticles for chemotherapy: in vitro approach through efflux-transporter modulation.
Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Biological Transport; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Therapy; Isothiocyanates; Lipids; Nanoparticles; Nifedipine; Particle Size; Tamoxifen; Verapamil | 2008 |
Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system.
Topics: Alginates; Calorimetry, Differential Scanning; Chitosan; Cross-Linking Reagents; Drug Carriers; Drug Compounding; Estrogen Antagonists; Glucuronic Acid; Hexuronic Acids; Microscopy, Electron, Scanning; Particle Size; Peyer's Patches; Rheology; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tamoxifen | 2009 |
Role of the pharmaceutical excipients in the tamoxifen activity on MCF-7 and vero cell cultures.
Topics: Alginates; Animals; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Chitosan; Chlorocebus aethiops; Excipients; Glucuronic Acid; Hexuronic Acids; Humans; Particle Size; Tamoxifen; Vero Cells | 2009 |
Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.
Topics: Biological Availability; Chitosan; Chromatography, High Pressure Liquid; Drug Compounding; Drug Delivery Systems; Electrochemistry; Estrogen Antagonists; Excipients; Lactic Acid; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tamoxifen | 2010 |
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake.
Topics: Antineoplastic Agents; Biological Transport; Caco-2 Cells; Cell Survival; Chitosan; Drug Delivery Systems; Gastric Juice; Humans; Intestinal Secretions; Lecithins; Lipase; MCF-7 Cells; Muramidase; Nanoparticles; Pancreatin; Progesterone; Tamoxifen | 2013 |
Synthesis and characterisation of alginate/chitosan nanoparticles as tamoxifen controlled delivery systems.
Topics: Alginates; Antineoplastic Agents, Hormonal; Chitosan; Delayed-Action Preparations; Glucuronic Acid; Hexuronic Acids; Nanoparticles; Tamoxifen | 2013 |
Transporting antitumor drug tamoxifen and its metabolites, 4-hydroxytamoxifen and endoxifen by chitosan nanoparticles.
Topics: Chitosan; Drug Delivery Systems; Models, Molecular; Molecular Conformation; Molecular Structure; Nanoparticles; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Tamoxifen | 2013 |
pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Chitosan; Drug Carriers; Drug Delivery Systems; Endocytosis; Female; Humans; Hydrogen-Ion Concentration; Light; MCF-7 Cells; Models, Biological; Nanoparticles; Particle Size; Scattering, Radiation; Static Electricity; Tamoxifen; Time Factors | 2013 |
Applications of chitosan nanoparticles in drug delivery.
Topics: Antineoplastic Agents; Binding Sites; Chitosan; Doxorubicin; Drug Carriers; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Kinetics; Nanoparticles; Porosity; Tamoxifen; Thermodynamics | 2014 |
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles.
Topics: Animals; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Intestinal Mucosa; Lecithins; Lipase; Male; Nanoparticles; Pancreatin; Permeability; Rats; Rats, Wistar; Tamoxifen | 2015 |
Chitosan-Stearic Acid Based Polymeric Micelles for the Effective Delivery of Tamoxifen: Cytotoxic and Pharmacokinetic Evaluation.
Topics: Animals; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Humans; Lipids; MCF-7 Cells; Micelles; Polymers; Rats, Wistar; Stearic Acids; Tamoxifen; Tissue Distribution | 2017 |
Polymeric micelles of amphiphilic graft copolymer of α-tocopherol succinate-g-carboxymethyl chitosan for tamoxifen delivery: Synthesis, characterization and in vivo pharmacokinetic study.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Biological Availability; Body Fluids; Chemistry Techniques, Synthetic; Chitosan; Drug Carriers; Drug Liberation; Hydrophobic and Hydrophilic Interactions; Micelles; Molecular Weight; Polymerization; Rats; Rats, Sprague-Dawley; Solvents; Tamoxifen | 2016 |
Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen.
Topics: Administration, Topical; Animals; Breast Neoplasms; Chitosan; Drug Carriers; Female; Humans; Lactic Acid; MCF-7 Cells; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Skin Absorption; Tamoxifen | 2016 |
Potential of amphiphilic graft copolymer α-tocopherol succinate-g-carboxymethyl chitosan in modulating the permeability and anticancer efficacy of tamoxifen.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Chitosan; Drug Carriers; Female; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Micelles; Permeability; Polymers; Rats; Rats, Sprague-Dawley; Tamoxifen | 2017 |
Chitosan-palmitic acid based polymeric micelles as promising carrier for circumventing pharmacokinetic and drug delivery concerns of tamoxifen.
Topics: Animals; Chitosan; Drug Carriers; Drug Liberation; Hemolysis; Humans; MCF-7 Cells; Micelles; Palmitic Acid; Particle Size; Polymers; Rats; Rats, Wistar; Tamoxifen | 2017 |
Design of functionalized folic acid-chitosan nanoparticles for delivery of tetracycline, doxorubicin, and tamoxifen.
Topics: Chitosan; Doxorubicin; Drug Carriers; Folic Acid; Microscopy, Electron, Transmission; Nanoparticles; Spectroscopy, Fourier Transform Infrared; Tamoxifen; Tetracyclines; Thermodynamics | 2019 |
Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Cholesterol; Delayed-Action Preparations; Drug Liberation; Female; Gold; Hexoses; Hydrogen-Ion Concentration; Liposomes; Metal Nanoparticles; Mice; Tamoxifen; Tissue Distribution | 2018 |
Tamoxifen citrate loaded chitosan-gellan nanocapsules for breast cancer therapy: development, characterisation and in-vitro cell viability study.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Survival; Chitosan; Drug Liberation; Female; Humans; MCF-7 Cells; Nanocapsules; Polysaccharides, Bacterial; Tamoxifen | 2018 |
Local and controlled release of tamoxifen from multi (layer-by-layer) alginate/chitosan complex systems.
Topics: Alginates; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Diffusion; Drug Liberation; Humans; Tamoxifen; Wettability | 2019 |
Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells.
Topics: Chitosan; Drug Carriers; Humans; Hyaluronic Acid; MCF-7 Cells; Nanoparticles; Particle Size; Tamoxifen | 2022 |
Effect of nanovesicular surface-functionalization via chitosan and/or PEGylation on cytotoxicity of tamoxifen in induced-breast cancer model.
Topics: Animals; Annexins; Apoptosis; bcl-2-Associated X Protein; Caspase 9; Chitosan; Liposomes; Necrosis; Neoplasms; Polyethylene Glycols; Rats; Tamoxifen | 2022 |